10,632 Shares in Cardinal Health, Inc. (NYSE:CAH) Bought by Castlekeep Investment Advisors LLC

Castlekeep Investment Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,632 shares of the company's stock, valued at approximately $1,257,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CAH. Norges Bank bought a new stake in Cardinal Health in the 4th quarter valued at $246,748,000. Marshall Wace LLP increased its holdings in shares of Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after purchasing an additional 1,913,892 shares during the last quarter. Junto Capital Management LP bought a new position in shares of Cardinal Health in the fourth quarter valued at about $92,811,000. Woodline Partners LP acquired a new stake in shares of Cardinal Health during the 4th quarter worth about $87,144,000. Finally, 8 Knots Management LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth about $62,476,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

CAH stock traded up $0.53 during midday trading on Thursday, reaching $153.66. The company had a trading volume of 457,060 shares, compared to its average volume of 2,222,143. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $156.44. The stock has a 50 day moving average price of $140.85 and a 200-day moving average price of $129.83. The company has a market capitalization of $36.68 billion, a price-to-earnings ratio of 28.67, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business's revenue for the quarter was up .0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.08 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.33%. Cardinal Health's dividend payout ratio is presently 31.83%.

Analysts Set New Price Targets

CAH has been the topic of several research analyst reports. Morgan Stanley increased their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a report on Monday, May 5th. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Mizuho boosted their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Robert W. Baird upped their price objective on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Finally, Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $146.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.